Frédéric Delobel
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Liver physiology and pathology
Papers in
-
- Cerebrovascular and genetic disorders 2
-
- Drug-Induced Hepatotoxicity and Protection 2
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Nadège Blanchard (2 shared papers)Thierry Lavé (2 shared papers)Lysiane Richert (2 shared papers)Philippe Coassolo (2 shared papers)Roberto Iacone (3 shared papers)Esther Melo (2 shared papers)Peter Jakob (2 shared papers)Tom Dunkley (2 shared papers)
- Journals
- Matrix Biology (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Scientific Reports (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Cell chemical biology (1 paper)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Frédéric Delobel
5 papers receiving 145 citations
Peers
Comparison fields: 5 of 49
- Pharmacology 59
- Hepatology 14
- Oncology 43
- Ophthalmology 14
- Neurology 21
Countries citing papers authored by Frédéric Delobel
This map shows the geographic impact of Frédéric Delobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Delobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Delobel more than expected).
Fields of papers citing papers by Frédéric Delobel
This network shows the impact of papers produced by Frédéric Delobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Delobel. The network helps show where Frédéric Delobel may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Delobel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 47 | |
| 2 | 2018 | 29 | |
| 3 | 2017 | 27 | |
| 4 | 2006 | 27 | |
| 5 | 2017 | 20 |
About Frédéric Delobel
Frédéric Delobel is a scholar working on Neurology, Pharmacology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology, having authored 5 papers that have together received 150 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cerebrovascular and genetic disorders (2 papers), Liver physiology and pathology (1 paper), Bioinformatics and Genomic Networks (1 paper), Retinal Diseases and Treatments (1 paper), Computational Drug Discovery Methods (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Pharmacology (59 citations), Hepatology (14 citations), Oncology (43 citations), Ophthalmology (14 citations) and Neurology (21 citations). Frédéric Delobel has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Nadège Blanchard, Thierry Lavé, Lysiane Richert, Philippe Coassolo, Roberto Iacone, Esther Melo, Peter Jakob, Tom Dunkley, Oliver Schilling and Pascale David‐Pierson. Their work appears in journals such as Matrix Biology, European Journal of Pharmaceutics and Biopharmaceutics, Scientific Reports, European Journal of Pharmaceutical Sciences and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.